Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALICIA SERAFINO

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1528742962
CMS profile
11543078
Location
ASHTABULA, OH

General Payments · PY2023–2024

$978.62

  • Reported across 34 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$585.71

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $585.71 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $124.89 1
Amgen Inc. $114.24 1
Lilly USA, LLC $103.98 1
ABBVIE INC. $80.35 3
Janssen Pharmaceuticals, Inc $50.91 1
Sumitomo Pharma America, Inc. $48.09 3
Organon LLC $28.17 4
SHIELD THERAPEUTICS INC $20.72 1
Sage Therapeutics, Inc. $14.36 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $392.91 18
PY2024 $585.71 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $26.63 01/03/2024 Food and Beverage Undisputed 01/23/2026 1108173860 CMS
ABBVIE INC. $27.39 01/23/2024 Food and Beverage Undisputed 01/23/2026 1108173862 CMS
ABBVIE INC. $26.33 01/24/2024 Food and Beverage Undisputed 01/23/2026 1108173864 CMS
Amgen Inc. $114.24 03/19/2024 Food and Beverage Undisputed 01/23/2026 1116102659 CMS
Janssen Pharmaceuticals, Inc $50.91 09/20/2024 Food and Beverage Undisputed 01/23/2026 1078124200 CMS
Lilly USA, LLC $103.98 09/26/2024 Food and Beverage Undisputed 01/23/2026 1135525271 CMS
Novo Nordisk Inc $124.89 10/03/2024 Food and Beverage Undisputed 01/23/2026 1100336190 CMS
Organon Llc $1.49 06/04/2024 Food and Beverage Undisputed 01/23/2026 1136217998 CMS
Organon Llc $10.43 06/04/2024 Food and Beverage Undisputed 01/23/2026 1136218002 CMS
Organon Llc $0.16 11/05/2024 Food and Beverage Undisputed 01/23/2026 1136218007 CMS
Organon Llc $16.09 11/05/2024 Food and Beverage Undisputed 01/23/2026 1136218010 CMS
Sage Therapeutics, Inc. $14.36 04/05/2024 Food and Beverage Undisputed 01/23/2026 1120396635 CMS
SHIELD THERAPEUTICS INC $20.72 10/08/2024 Food and Beverage Undisputed 01/23/2026 1150148845 CMS
Sumitomo Pharma America, Inc. $13.72 04/22/2024 Food and Beverage Undisputed 01/23/2026 1148994068 CMS
Sumitomo Pharma America, Inc. $17.21 05/20/2024 Food and Beverage Undisputed 01/23/2026 1148994070 CMS
Sumitomo Pharma America, Inc. $17.16 07/29/2024 Food and Beverage Undisputed 01/23/2026 1148994072 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.